|
시장보고서
U.S. Injectable Drug Pipeline
|
Abstract
This research service covers the U.S. injectable drug pipeline in 2009.
Included are technology trends, Phase III pipeline analysis, selected Phase II
and I pipeline analysis. The market is segmented by injectable drug delivery
route: subcutaneous injectables, intravenous injectables, intramuscular
injectables, and others. Major market challenges, drivers, and restraints and
identified and discussed as well as hot topics and trends relating to
injectable drug development.
Table of Contents
1. EXECUTIVE SUMMARY
Executive Summary
2. MARKET OVERVIEW
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Introduction
- Introduction
- Hot Topics and Trends
- Patient Willingness to Use Injection Types
- Leading Companies
- Industry Challenges
- Market Drivers
- Market Restraints
3. PIPELINE ANALYSIS
Introduction
Intramuscular Injectable Drugs
- Introduction
- Phase III
- Phase II/III
- Phase II
- Phase I/II
- Phase I
Subcutaneous Injectable Drugs
- Introduction
- Phase III
- Phase II/III
- Phase II
- Phase I/II
- Phase I
Intravenous Injectable Drugs
- Introduction
- Phase III
- Phase II/III
- Phase II
- Phase I/II
- Phase I
Other Injectable Drugs
- Introduction
- Phase III
- Phase II/III
- Phase II
- Phase I/II
- Phase I
4. DECISION SUPPORT DATABASES
Oncology Databases
- Incidence of Colon Rectum Cancer
- Total Cancer Cases
- Incidence of Bladder Cancer
- Incidence of Breast Cancer
- Incidence of Lung Cancer
- Incidence of Stomach Cancer
Autoimmune and Inflammatory Disorders Databases
- Prevalence of Asthma
- Prevalence of Arthritis
- Total Cases of Multiple Sclerosis
- Prevalence of Psoriasis
Cardiovascular Disorders Databases
- Prevalence of Cardiovascular Diseases
- Prevalence of Coronary Heart Disease
|
